A carregar...
Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy
Background Few data are available outlining outcomes of panitumumab in advanced colorectal cancer patients benefiting from prior cetuximab-based regimens. Patients and methods Thirty patients with KRAS wild type metastatic colorectal cancer with clinical benefit from prior cetuximab-based regimens b...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Landes Bioscience
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3912032/ https://ncbi.nlm.nih.gov/pubmed/24025413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26343 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|